• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肌炎相关肝细胞癌的风险预测。

Risk prediction for dermatomyositis-associated hepatocellular carcinoma.

机构信息

Ningxia Medical University, Yinchuan, 750004, China.

Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.

出版信息

BMC Bioinformatics. 2023 May 31;24(1):222. doi: 10.1186/s12859-023-05353-6.

DOI:10.1186/s12859-023-05353-6
PMID:37259059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10233868/
Abstract

OBJECTIVE

To explore dermatomyositis signature genes as potential biomarkers of hepatocellular carcinoma and their associated molecular regulatory mechanisms.

METHODS

Based on the mRNA-Seq data of dermatomyositis and hepatocellular carcinoma in public databases, five dermatomyositis signature genes were screened by LASSO regression analysis and support vector machine (SVM) algorithm, and their biological functions in dermatomyositis with hepatocellular carcinoma were investigated, and a nomogram risk prediction model for hepatocellular carcinoma was constructed and its predictive efficiency was initially evaluated. The immune profile in hepatocellular carcinoma was examined based on the CIBERSORT and ssGSEA algorithms, and the correlation between five dermatomyositis signature genes and tumor immune cell infiltration and immune checkpoints in hepatocellular carcinoma was investigated.

RESULTS

The expression levels of five dermatomyositis signature genes were significantly altered in hepatocellular carcinoma and showed good diagnostic efficacy for hepatocellular carcinoma, suggesting that they may be potential predictive targets for hepatocellular carcinoma, and the risk prediction model based on five dermatomyositis signature genes showed good risk prediction efficacy for hepatocellular carcinoma and has good potential for clinical application. In addition, we also found that the upregulation of SPP1 expression may activate the PI3K/ART signaling pathway through integrin-mediated activation, which in turn regulates the development and progression of hepatocellular carcinoma.

CONCLUSION

LY6E, IFITM1, GADD45A, MT1M, and SPP1 are potential predictive targets for new-onset hepatocellular carcinoma in patients with dermatomyositis, and the upregulation of SPP1 expression may activate the PI3K/ART signaling pathway through the mediation of integrins to promote the development and progression of hepatocellular carcinoma.

摘要

目的

探索皮肌炎特征基因作为肝细胞癌潜在生物标志物及其相关分子调控机制。

方法

基于公共数据库中皮肌炎和肝细胞癌的 mRNA-Seq 数据,通过 LASSO 回归分析和支持向量机(SVM)算法筛选出 5 个皮肌炎特征基因,研究其在伴发肝细胞癌的皮肌炎中的生物学功能,并构建肝细胞癌的列线图风险预测模型,初步评估其预测效能。基于 CIBERSORT 和 ssGSEA 算法检测肝细胞癌的免疫图谱,研究 5 个皮肌炎特征基因与肝细胞癌肿瘤免疫细胞浸润和免疫检查点的相关性。

结果

5 个皮肌炎特征基因在肝细胞癌中的表达水平明显改变,对肝细胞癌具有良好的诊断效能,提示其可能是肝细胞癌的潜在预测靶点,基于 5 个皮肌炎特征基因的风险预测模型对肝细胞癌具有良好的风险预测效能,具有良好的临床应用潜力。此外,我们还发现 SPP1 表达的上调可能通过整合素介导的激活激活 PI3K/ART 信号通路,进而调节肝细胞癌的发生和发展。

结论

LY6E、IFITM1、GADD45A、MT1M 和 SPP1 是皮肌炎患者新发肝细胞癌的潜在预测靶点,SPP1 表达的上调可能通过整合素的介导激活 PI3K/ART 信号通路,促进肝细胞癌的发生和发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/0f8746782121/12859_2023_5353_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/2c3f557eaa9a/12859_2023_5353_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/d7e73490e373/12859_2023_5353_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/c23f197ea229/12859_2023_5353_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/c8f5a72e631a/12859_2023_5353_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/64267bcf4338/12859_2023_5353_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/173d426c5576/12859_2023_5353_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/1ef53d429c61/12859_2023_5353_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/55e4f7e74acf/12859_2023_5353_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/0f8746782121/12859_2023_5353_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/2c3f557eaa9a/12859_2023_5353_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/d7e73490e373/12859_2023_5353_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/c23f197ea229/12859_2023_5353_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/c8f5a72e631a/12859_2023_5353_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/64267bcf4338/12859_2023_5353_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/173d426c5576/12859_2023_5353_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/1ef53d429c61/12859_2023_5353_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/55e4f7e74acf/12859_2023_5353_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ca1/10233868/0f8746782121/12859_2023_5353_Fig9_HTML.jpg

相似文献

1
Risk prediction for dermatomyositis-associated hepatocellular carcinoma.皮肌炎相关肝细胞癌的风险预测。
BMC Bioinformatics. 2023 May 31;24(1):222. doi: 10.1186/s12859-023-05353-6.
2
Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.基于 WGCNA 和 LASSO 算法构建巨噬细胞相关的 4 基因signature 及列线图预测肝细胞癌患者总生存期
Int Immunopharmacol. 2021 Jan;90:107238. doi: 10.1016/j.intimp.2020.107238. Epub 2020 Dec 11.
3
Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.基于 WGCNA 和 LASSO 算法的肝癌巨噬细胞相关基因特征的预后、免疫特征和免疫治疗生物标志物的综合分子分析。
Front Immunol. 2022 May 27;13:843408. doi: 10.3389/fimmu.2022.843408. eCollection 2022.
4
Identification of Biomarkers Associated With CD4 T-Cell Infiltration With Gene Coexpression Network in Dermatomyositis.鉴定与皮肌炎中 CD4+T 细胞浸润相关的生物标志物的基因共表达网络分析。
Front Immunol. 2022 May 30;13:854848. doi: 10.3389/fimmu.2022.854848. eCollection 2022.
5
Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.鉴定和描述一个 25-lncRNA 预后标志物用于预测肝细胞癌早期复发。
BMC Cancer. 2021 Oct 30;21(1):1165. doi: 10.1186/s12885-021-08827-z.
6
Five genes as diagnostic biomarkers of dermatomyositis and their correlation with immune cell infiltration.五种用于诊断皮肌炎的基因标志物及其与免疫细胞浸润的相关性。
Front Immunol. 2023 Jan 18;14:1053099. doi: 10.3389/fimmu.2023.1053099. eCollection 2023.
7
Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.基于氧化还原免疫的肝细胞癌预后标志物的鉴定和验证。
Int J Med Sci. 2021 Mar 10;18(9):2030-2041. doi: 10.7150/ijms.56289. eCollection 2021.
8
Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.基于单样本基因集富集分析(ssGSEA)算法的免疫相关基因特征在肝细胞癌预后及免疫格局中的综合分析
Front Genet. 2022 Dec 9;13:1064432. doi: 10.3389/fgene.2022.1064432. eCollection 2022.
9
A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.一个与坏死性凋亡相关的基因特征,可用于预测肝细胞癌的预后、免疫图谱和药物敏感性。
Cancer Med. 2022 Dec;11(24):5079-5096. doi: 10.1002/cam4.4812. Epub 2022 May 13.
10
A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration.基于免疫相关基因的新型肝癌风险评分作为可靠的预后生物标志物,并与免疫浸润相关。
Front Immunol. 2022 Oct 24;13:1023349. doi: 10.3389/fimmu.2022.1023349. eCollection 2022.

引用本文的文献

1
Development of a Starvation Response-Based Model and Its Application in Prognostic Assessment of Liver Hepatocellular Carcinoma.基于饥饿反应的模型的开发及其在肝细胞癌预后评估中的应用
Mediators Inflamm. 2025 Jul 7;2025:8828435. doi: 10.1155/mi/8828435. eCollection 2025.
2
Altered LY6E and TRIM6 expression in PBMCs correlated with HBsAg clearance and response to Peg-IFN-α treatment in HBeAg-negative chronic hepatitis B patients.外周血单个核细胞中LY6E和TRIM6表达的改变与HBeAg阴性慢性乙型肝炎患者的HBsAg清除及对聚乙二醇干扰素-α治疗的反应相关。
Virol J. 2025 Mar 15;22(1):74. doi: 10.1186/s12985-025-02689-8.

本文引用的文献

1
MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.MYC 和 MET 协同驱动具有不同分子特征和脆弱性的肝细胞癌。
Cell Death Dis. 2022 Nov 24;13(11):994. doi: 10.1038/s41419-022-05411-6.
2
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence.副肿瘤性抗Tif1-γ自身抗体阳性皮肌炎作为肝细胞癌复发的临床表现
J Clin Transl Hepatol. 2023 Feb 28;11(1):253-259. doi: 10.14218/JCTH.2021.00573. Epub 2022 May 24.
3
Single Cell RNA-Seq Identifies Immune-Related Prognostic Model and Key Signature-SPP1 in Pancreatic Ductal Adenocarcinoma.
单细胞 RNA-Seq 鉴定胰腺导管腺癌的免疫相关预后模型和关键特征标志物 SPP1。
Genes (Basel). 2022 Sep 29;13(10):1760. doi: 10.3390/genes13101760.
4
SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma.在肺腺癌中,SPP1通过靶向COL11A1促进细胞迁移和侵袭。
Cancer Cell Int. 2022 Oct 20;22(1):324. doi: 10.1186/s12935-022-02749-x.
5
SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma.源自巨噬细胞的SPP1与肺腺癌更差的临床病程和化疗耐药相关。
Cancers (Basel). 2022 Sep 8;14(18):4374. doi: 10.3390/cancers14184374.
6
Adult and juvenile dermatomyositis treatment.成人和青少年皮肌炎的治疗。
J Cosmet Dermatol. 2023 Feb;22(2):395-401. doi: 10.1111/jocd.15363. Epub 2022 Sep 16.
7
Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.血清抗 SPP1 自身抗体作为一种潜在的新型生物标志物用于检测食管鳞状细胞癌。
BMC Cancer. 2022 Aug 29;22(1):932. doi: 10.1186/s12885-022-10012-9.
8
Histopathological risk factors for malignancy in dermatomyositis.皮肌炎中恶性肿瘤的组织病理学危险因素。
Histopathology. 2022 Oct;81(4):529-535. doi: 10.1111/his.14727. Epub 2022 Aug 4.
9
SPP1 as a key gene in the lymph node metastasis and a potential predictor of poor prognosis in head and neck carcinoma.SPP1 作为淋巴结转移的关键基因,是头颈部癌不良预后的潜在预测因子。
J Oral Pathol Med. 2022 Aug;51(7):620-629. doi: 10.1111/jop.13333. Epub 2022 Aug 4.
10
Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis.DDR2 和 IFITM1 的共表达促进乳腺癌细胞的增殖、迁移和侵袭,抑制细胞凋亡。
J Cancer Res Clin Oncol. 2022 Dec;148(12):3385-3398. doi: 10.1007/s00432-022-04110-1. Epub 2022 Jun 28.